Found: 293
Select item for more details and to access through your institution.
Improved Sleep Quality Improves Blood Pressure Control among Patients with Chronic Kidney Disease: A Pilot Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Intradialytic Hypotension: Is Midodrine the Answer?
- Published in:
- 2018
- By:
- Publication type:
- editorial
Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease.
- Published in:
- Nephrology Dialysis Transplantation, 2006, v. 21, n. 9, p. 2366, doi. 10.1093/ndt/gfl309
- By:
- Publication type:
- Article
Long‐term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin‐converting enzymes/angiotensin receptor blockers: results from AMETHYST‐DN.
- Published in:
- ESC Heart Failure, 2018, v. 5, n. 4, p. 592, doi. 10.1002/ehf2.12292
- By:
- Publication type:
- Article
Calcium Antagonism Abolishes the Antipressor Action of Vasopressin (V<sub>1</sub>) Receptor Antagonism.
- Published in:
- American Journal of Hypertension, 1997, v. 10, n. 10, p. 1153, doi. 10.1016/S0895-7061(97)00216-1
- By:
- Publication type:
- Article
Salt intake and reductions in arterial pressure and proteinuria is there a direct link?
- Published in:
- American Journal of Hypertension, 1996, v. 9, p. 200S, doi. 10.1016/S0895-7061(96)00392-5
- By:
- Publication type:
- Article
Dual Therapy in Hypertensive Patients with Coronary Artery Disease: The Role of Calcium Channel Blockers and β-Blockers.
- Published in:
- American Journal of Cardiovascular Drugs, 2007, v. 7, p. 25, doi. 10.2165/00129784-200707001-00004
- By:
- Publication type:
- Article
Slowing the Progression of Diabetic Kidney Disease.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 15, p. 1975, doi. 10.3390/cells12151975
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. C1, doi. 10.1111/dom.15423
- By:
- Publication type:
- Article
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 191, doi. 10.1111/dom.15305
- By:
- Publication type:
- Article
Back Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. C4, doi. 10.1111/dom.15286
- By:
- Publication type:
- Article
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2989, doi. 10.1111/dom.15197
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1, doi. 10.1111/dom.15115
- By:
- Publication type:
- Article
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1512, doi. 10.1111/dom.14999
- By:
- Publication type:
- Article
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1413, doi. 10.1111/dom.14978
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. C1, doi. 10.1111/dom.14960
- By:
- Publication type:
- Article
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon‐like peptide‐1 receptor agonist use.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 407, doi. 10.1111/dom.14883
- By:
- Publication type:
- Article
External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 229, doi. 10.1111/dom.14867
- By:
- Publication type:
- Article
Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1197, doi. 10.1111/dom.14696
- By:
- Publication type:
- Article
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 125, doi. 10.1111/dom.14558
- By:
- Publication type:
- Article
Non‐steroidal mineralocorticoid antagonists: Prospects for renoprotection in diabetic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, p. 69, doi. 10.1111/dom.13983
- By:
- Publication type:
- Article
Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
High‐sensitivity C‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 654, doi. 10.1111/dom.13136
- By:
- Publication type:
- Article
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 664, doi. 10.1111/dom.12871
- By:
- Publication type:
- Article
The message for World Kidney Day 2009: Hypertension and kidney disease: A marriage that should be prevented.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation.
- Published in:
- 2002
- By:
- Publication type:
- journal article
A clinician's perspective of the role of renal sympathetic nerves in hypertension.
- Published in:
- Frontiers in Physiology, 2015, v. 6, p. 1, doi. 10.3389/fphys.2015.00075
- By:
- Publication type:
- Article
Carvedilol, Metoprolol, and Insulin Resistance.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension: A Randomized Controlled Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 18, p. 2227, doi. 10.1001/jama.292.18.2227
- By:
- Publication type:
- Article
A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease: The International Verapamil-Trandolapril Study (INVEST): A Randomized Controlled Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 290, n. 21, p. 2805, doi. 10.1001/jama.290.21.2805
- By:
- Publication type:
- Article
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 289, n. 19, p. 2560, doi. 10.1001/jama.289.19.2560
- By:
- Publication type:
- Article
Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with...
- Published in:
- Annals of Internal Medicine, 1996, v. 125, n. 3, p. 201, doi. 10.7326/0003-4819-125-3-199608010-00007
- By:
- Publication type:
- Article
Angiotensin--converting Enzyme Inhibitors and Progression of Diabetic Nephropathy.
- Published in:
- Annals of Internal Medicine, 1993, v. 118, n. 8, p. 643, doi. 10.7326/0003-4819-118-8-199304150-00013
- By:
- Publication type:
- Article
Effects of different calcium antagonists on proteinuria associated with diabetes mellitus.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.
- Published in:
- Vascular Medicine, 2002, v. 7, n. 1, p. 35, doi. 10.1191/1358863x02vm412ra
- By:
- Publication type:
- Article
Acute Interstitial Nephritis with Glomerulopathy Due to Nonsteroidal Anti-Inflammatory Agents: A Review of Its Clinical Spectrum and Effects of Steroid Therapy.
- Published in:
- 1990
- By:
- Publication type:
- Other
The Effects of Enalapril on Urinary Protein Excretion in Patients with Idiopathic Membranous Nephropathy.
- Published in:
- 1990
- By:
- Publication type:
- Other
Recent BP trials and JNC 7: What they mean in practice.
- Published in:
- Patient Care (Print), 2003, v. 37, n. 7, p. 17
- By:
- Publication type:
- Article
Early Patterns of Blood Pressure Change and Future Coronary Atherosclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Effect of Aliskiren on Progression of Coronary Disease in Patients With Prehypertension.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 310, n. 11, p. 1135, doi. 10.1001/jama.2013.277169
- By:
- Publication type:
- Article
Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 1, p. 61, doi. 10.1001/jama.2010.884
- By:
- Publication type:
- Article
1118-P: Effect of Patiromer in Patients 75 Years or Older with Diabetic Kidney Disease and Hyperkalemia Receiving a RAAS Inhibitor.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1118-P
- By:
- Publication type:
- Article
Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evaluation of Hemocue Albumin 201 System in Comparison to Existing Semiquantitative Dipstick Testing for Urine Albumin Excretion.
- Published in:
- Diabetes, 2007, v. 56, p. A197
- By:
- Publication type:
- Article
Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone—Translational Aspects and Clinical Perspectives across Multiple Organ Systems.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 16, p. 9243, doi. 10.3390/ijms23169243
- By:
- Publication type:
- Article
Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 9, p. 596, doi. 10.1093/jnci/djq091
- By:
- Publication type:
- Article